CLINOLEIC

This brand name is authorized in Austria, Canada, Ecuador, Finland, France, New Zealand, Poland, Singapore, Spain, Turkey, UK.

Active ingredients

The drug CLINOLEIC contains a combination of these active pharmaceutical ingredients (APIs):

1	Olive oil, refined UNII 6UYK2W1W1E - OLIVE OIL
	Read more about Olive oil, refined
2	Soybean oil, refined UNII 241ATL177A - SOYBEAN OIL
	Read more about Soybean oil, refined

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B05BA02	Fat emulsions	B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05B I.V. solutions → B05BA Solutions for parenteral nutrition
Discover more medicines within B05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02344327
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28541-08-08
ES	Centro de información online de medicamentos de la AEMPS	61977
FI	Lääkealan turvallisuus- ja kehittämiskeskus	066121, 497368
FR	Base de données publique des médicaments	67984396
GB	Medicines & Healthcare Products Regulatory Agency	151303, 151393, 348697
NZ	Medicines and Medical Devices Safety Authority	10049
PL	Rejestru Produktów Leczniczych	100110062
SG	Health Sciences Authority	12439P
TR	İlaç ve Tıbbi Cihaz Kurumu	8681413880995, 8681413881008, 8681413881015, 8681413881022